LRRK2 and the p.G2019S mutation in neuronal and systemic response to induced α-synuclein pathobiology
Parkinson’s disease (PD) is a progressive neurodegenerative disorder for which no disease-modifying treatments are currently available. PD is neuropathologically characterized by selective degeneration of nigral dopaminergic neurons and the presence of intraneuronal inclusions comprised primarily of...
| Main Author: | |
|---|---|
| Language: | English |
| Published: |
University of British Columbia
2016
|
| Online Access: | http://hdl.handle.net/2429/58667 |